title: Changes in endothelin receptor type B and neuronal nitric oxide synthase in puromycin aminonucleoside-induced nephrotic syndrome.
abstract: The collecting duct endothelin (ET) system, which involves ET-1 and its two receptors, may play a role in the regulation of renal sodium in association with the nitric oxide synthase (NOS) system. We determined whether sodium retention is associated with changes in the endothelin and NOS systems at different stages (i.e., a sodium retaining stage and a compensatory stage) of nephrotic syndromes. On day 7 after puromycin aminonucleoside (PAN) injection, urinary sodium excretion was decreased, ascites had developed, and there was a positive sodium balance. ET-1 mRNA expression was increased in the inner medulla of the kidney, whereas protein expression of ET receptor type B (ET(B)R) was unchanged. The expression of neuronal NOS (nNOS) was decreased in the inner medulla. On day 14, urinary sodium excretion was unchanged compared with controls. The expression of ET(B)R increased, while nNOS expression in the inner medulla was comparable to controls. These findings suggest that decreased nNOS plays a role in the development of sodium retention in the nephrotic syndrome. Recovery of nNOS and increased renal ET(B)R synthesis may promote sodium excretion in later stages of the nephrotic syndrome (on day 14).
authors.affiliation: Department of Internal Medicine, Chonnam National University Medical School, Gwangju 501-757, Korea.
authors.forename: Eun Hui
authors.initials: EH
authors.lastname: Bae
authors.forename: Soo Wan
authors.initials: SW
authors.lastname: Kim
references.citation: Hypertension. 2000 Mar;35(3):732-9
references.pmid: 10720587
references.citation: J Clin Invest. 1992 Mar;89(3):761-5
references.pmid: 1311716
references.citation: Curr Opin Nephrol Hypertens. 2006 Jan;15(1):34-40
references.pmid: 16340664
references.citation: Kidney Int. 2006 Jan;69(1):89-98
references.pmid: 16374428
references.citation: Hypertension. 1997 Jan;29(1 Pt 2):194-8
references.pmid: 9039101
references.citation: J Am Soc Nephrol. 1992 Mar;2(9):1371-87
references.pmid: 1627761
references.citation: Methods. 2001 Dec;25(4):402-8
references.pmid: 11846609
references.citation: Pediatr Nephrol. 2001 Mar;16(3):283-93
references.pmid: 11322379
references.citation: Clin Exp Pharmacol Physiol. 1999 Mar;26(3):262-8
references.pmid: 10081625
references.citation: Am J Physiol Renal Physiol. 2000 Aug;279(2):F326-33
references.pmid: 10919853
references.citation: Am J Physiol Renal Physiol. 2006 Jun;290(6):F1315-9
references.pmid: 16380457
references.citation: Am J Physiol Renal Physiol. 2001 Jul;281(1):F144-50
references.pmid: 11399655
references.citation: Am J Physiol Renal Physiol. 2008 Oct;295(4):F1063-70
references.pmid: 18667482
references.citation: Am J Kidney Dis. 1997 Jan;29(1):2-26
references.pmid: 9002526
references.citation: Hypertension. 2009 Feb;53(2):324-30
references.pmid: 19104001
references.citation: Am J Physiol. 1998 Apr;274(4):F766-74
references.pmid: 9575902
references.citation: Am J Physiol Renal Physiol. 2006 Dec;291(6):F1274-80
references.pmid: 16868309
references.citation: J Biol Chem. 1994 Aug 26;269(34):21778-85
references.pmid: 7520443
references.citation: J Am Soc Nephrol. 2005 Nov;16(11):3196-210
references.pmid: 16192424
references.citation: Kidney Int. 1994 Feb;45(2):336-44
references.pmid: 8164417
references.citation: J Am Soc Nephrol. 2000 Apr;11(4):604-615
references.pmid: 10752519
references.citation: Am J Physiol Renal Physiol. 2008 May;294(5):F1205-11
references.pmid: 18305094